BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24582913)

  • 21. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE).
    Donadieu J; Auclerc MF; Baruchel A; Perel Y; Bordigoni P; Landman-Parker J; Leblanc T; Cornu G; Sommelet D; Leverger G; Schaison G; Hill C;
    Br J Cancer; 2000 Dec; 83(12):1617-22. PubMed ID: 11104555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
    Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M
    Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
    Pollock BH; DeBaun MR; Camitta BM; Shuster JJ; Ravindranath Y; Pullen DJ; Land VJ; Mahoney DH; Lauer SJ; Murphy SB
    J Clin Oncol; 2000 Feb; 18(4):813-23. PubMed ID: 10673523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The incidence of and mortality from leukaemias in the UK: a general population-based study.
    Bhayat F; Das-Gupta E; Smith C; McKeever T; Hubbard R
    BMC Cancer; 2009 Jul; 9():252. PubMed ID: 19630999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study.
    Perrillat F; Clavel J; Auclerc MF; Baruchel A; Leverger G; Nelken B; Philippe N; Schaison G; Sommelet D; Vilmer E; Hémon D
    Br J Cancer; 2002 Apr; 86(7):1064-9. PubMed ID: 11953850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.
    Kadan-Lottick NS; Ness KK; Bhatia S; Gurney JG
    JAMA; 2003 Oct; 290(15):2008-14. PubMed ID: 14559954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Young age at diagnosis is a risk factor for negative late socio-economic effects after acute lymphoblastic leukemia in childhood.
    Holmqvist AS; Wiebe T; Hjorth L; Lindgren A; Øra I; Moëll C
    Pediatr Blood Cancer; 2010 Oct; 55(4):698-707. PubMed ID: 20589625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term survival after childhood acute lymphoblastic leukaemia: population-based trends in cure and relapse by clinical characteristics.
    Smith L; Glaser AW; Kinsey SE; Greenwood DC; Chilton L; Moorman AV; Feltbower RG
    Br J Haematol; 2018 Sep; 182(6):851-858. PubMed ID: 29808915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socioeconomic status and event free survival in pediatric acute lymphoblastic leukemia: a population-based cohort study.
    Gupta S; Sutradhar R; Guttmann A; Sung L; Pole JD
    Leuk Res; 2014 Dec; 38(12):1407-12. PubMed ID: 25224660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in prognosis for children with acute lymphoblastic leukemia.
    Pui CH; Boyett JM; Relling MV; Harrison PL; Rivera GK; Behm FG; Sandlund JT; Ribeiro RC; Rubnitz JE; Gajjar A; Evans WE
    J Clin Oncol; 1999 Mar; 17(3):818-24. PubMed ID: 10071272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
    Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
    Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study.
    Thompson JR; Gerald PF; Willoughby ML; Armstrong BK
    Lancet; 2001 Dec; 358(9297):1935-40. PubMed ID: 11747917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrated evaluation of socioeconomic and clinical factors in the survival from childhood acute lymphoblastic leukaemia: a study in Greece.
    Charalampopoulou A; Petridou E; Spyridopoulos T; Dessypris N; Oikonomou A; Athanasiadou-Piperopoulou F; Baka M; Kalmanti M; Polychronopoulou S; Trichopoulos D
    Eur J Cancer Prev; 2004 Oct; 13(5):397-401. PubMed ID: 15452452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved outcome of acute lymphoblastic leukaemia treated by delayed intensification in Hong Kong children: HKALL97 study.
    Li CK; Chik KW; Ha SY; Lee AC; Yuen HL; Ling SC; Lee V; Chan GC; Shing MM; Chan LC; Ng MH
    Hong Kong Med J; 2006 Feb; 12(1):33-9. PubMed ID: 16495587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic field exposure and long-term survival among children with leukaemia.
    Foliart DE; Pollock BH; Mezei G; Iriye R; Silva JM; Ebi KL; Kheifets L; Link MP; Kavet R
    Br J Cancer; 2006 Jan; 94(1):161-4. PubMed ID: 16404370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.